This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Pernix Therapeutics Holdings Inc (PTX)

NASDAQ: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) -25.64M -1.41M 8.35M 9.31M
Operating Gains/Losses n.a. n.a. n.a. n.a.
Extraordinary Gains / Losses n.a. n.a. n.a. n.a.
(Increase) Decrease In Receivables n.a. n.a. n.a. n.a.
(Increase) Decrease in Inventories n.a. n.a. n.a. n.a.
(Increase) Decrease In Other Current Assets 12.16M -3.89M -5.84M -8.36M
(Decrease) Increase In Payables n.a. n.a. n.a. n.a.
(Decrease) Increase In Other Current Liabilities -5.73M -770.38K 6.46M 6.93M
(Increase) Decrease In Other Working Capital n.a. n.a. n.a. n.a.
Other Non-Cash Items 35.19M 5.98M 2.70M -155.70K
Net Cash From Continuing Operations n.a. n.a. n.a. n.a.
Net Cash From Discontinued Operations n.a. n.a. n.a. n.a.
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -6.53M -1.93M 9.40M 4.67M
Sale of Property, Plant & Equipment n.a. n.a. n.a. n.a.
Cash Used for Investing Activities
Sale of Short-Term Investments 4.61M 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -496.04K -318.74K -175.60K -119.58K
Acquisitions -309.59K -56.33M 0.00 -3.82M
Purchases of Short-Term Investments 0.00 0.00 -2.00M -1.50M
Other Cash from Investing Activities 19.59M -8.25M 0.00 -250.00K
Cash Provided by Financing Activities
Net Cash From Investing Activities 23.39M -64.90M -2.18M -5.70M
Issuance of Debt 0.00 0.00 1.00M 86.33K
Cash Used for Financing Activities
Issuance of Capital Stock 261.44K 24.59M 19.55M 77.60K
Repayment of Long-Term Debt -24.34M -3.54M 0.00 -501.91K
Repurchase of Capital Stock 0.00 0.00 0.00 -849.87K
Payment of Cash Dividends 0.00 0.00 0.00 -121.46K
Other Financing Charges, Net -151.50K 34.25M -1.48M 6.02M
Net Cash From Financing Activities -24.23M 55.29M 19.07M 4.71M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents -7.38M -11.53M 26.29M 3.68M
PTX News

PTX Pernix Therapeutics Holdings Inc

Analysts Ratings for PTX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 0
Moderate Buy 0 0 0 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET PTX ANALYST REPORT

Brokerage Partners

PTX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs